NZ273710A - use of ketoconazole or a derivative which is a cortisol synthesis inhibitor in medicaments for treatment of type II diabetes
- Google Patents
use of ketoconazole or a derivative which is a cortisol synthesis inhibitor in medicaments for treatment of type II diabetes
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cortendo AbfiledCriticalCortendo Ab
Priority to NZ27371094ApriorityCriticalpatent/NZ273710A/en
Publication of NZ273710ApublicationCriticalpatent/NZ273710A/en
Pharmaceuticals Containing Other Organic And Inorganic Compounds
(AREA)
Abstract
Ketoconazole or a derivative thereof having a corresponding activity as an inhibitor of cortisol synthesis is used in the manufacture of a medicament for the treatment of diabetes mellitus type II, for counteracting the risk factors being part of Metabolic Syndrome (Syndrome X) or for treating decreased insulin sensitivity, elevated blood lipids, hypertension or hyperinsulinemia.
NZ27371094A1994-08-091994-08-09use of ketoconazole or a derivative which is a cortisol synthesis inhibitor in medicaments for treatment of type II diabetes
NZ273710A
(en)
Drug delivery systems containing microtubule stabilizing agents and the use of said agents in the manufacture of a medicament for treating atherosclerosis or restenosis